Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 5/20 | 0.40 |
| ▸ | TMIGD3 | P0DMS9 | 4/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.37 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.37 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.37 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.37 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.36 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.36 |
| ▸ | CDK2 | P24941 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | GALR3 | O60755 | 1/20 | 0.35 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23453049 | 0.97 | TDP1 (0.41) | TDP1HDAC1HDAC2TMIGD3ADORA2A | |
| SCHEMBL23453058 | 0.95 | HDAC1 (0.41) | TDP1HDAC1HDAC2TMIGD3ADORA2A | |
| SCHEMBL23453050 | 0.92 | TDP1 (0.40) | TDP1HDAC1HDAC2TMIGD3ADORA2A | |
| SCHEMBL23453045 | 0.86 | PDE4A (0.38) | TDP1HDAC1HDAC2TMIGD3ADORA2A | |
| SCHEMBL23453066 | 0.84 | TDP1 (0.43) | TDP1HDAC1HDAC2TMIGD3ADORA2A | |
| SCHEMBL6803680 | 0.82 | TDP1 (0.40) | TDP1HDAC1HDAC2TMIGD3ADORA2A | |
| SCHEMBL7263078 | 0.82 | HDAC1 (0.41) | TDP1HDAC1HDAC2CCNE2CCNE1 | |
| SCHEMBL17739752 | 0.81 | GALR3 (0.40) | RXFP1CCNE2CCNE1CDK2MEN1 | |
| SCHEMBL23453046 | 0.80 | TMIGD3 (0.40) | TDP1HDAC1HDAC2TMIGD3ADORA2A | |
| SCHEMBL432254 | 0.80 | CCNE2 (0.40) | HDAC1HDAC2CCNE2CCNE1CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210163541-A1 | Method for Preparing PNA Oligomer | SEASUNBIO MATERIALS (KR) | 2021-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210163541-A1 | Method for Preparing PNA Oligomer | NCL, NOD1, POLI | TDP1 775/4885HDAC1 3118/4885HDAC2 2432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.